Back to public companies

CDIO Stock Research Snapshot: Pipeline, Catalysts, and Cash Runway

Cardio Diagnostics Holdings Inc | Needs refresh | Last updated: 2026-06-01T17:55:29Z

TickerCDIO
Market Cap6.3M
Cash RunwayRunway > 12 months
Next Catalystn/a

Public Research Snapshot

Cardio Diagnostics Holdings Inc is a publicly tracked healthcare company. This research snapshot summarizes public information on pipeline assets, clinical trials, upcoming catalysts, SEC filings, and cash runway estimates.

Pipeline

AssetIndicationModalityStagePublic Note
No public pipeline rows are loaded yet.

Catalyst Preview

No public catalyst rows matched this view yet.

Cash Runway Preview

Estimated cash runway: Runway > 12 months.

This is an automated estimate and may differ from company guidance.

Recent SEC Filings

  • No public filing rows are loaded yet.

Clinical Trial Activity

NCT IDPhaseStatusEnrollmentPrimary Completion
No public trial rows are loaded yet.

Scientific Context

  • literature_publication | Validity of the International Classification of Diseases, Tenth Revision codes in diagnosing myocardial infarction subtypes.
  • literature_publication | Economic burden associated with systemic inflammation in patients with HFmrEF/HFpEF.
  • literature_publication | Atorvastatin and left ventricular strain during anthracycline-based chemotherapy.
  • literature_publication | Prior Myocardial Infarction and Cognitive Decline: The REGARDS Cohort.
  • literature_publication | Characteristics of Unsuccessful Recanalization Following Endovascular Thrombectomy: Cohort Study (EVATRISP Collaboration).

This page is for informational and educational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell securities. Data may be incomplete or delayed. Cash runway and catalyst timing estimates are derived from public sources and may differ from company guidance.